What Needle Size Does Zepbound Use? Auto-Injector and Compounded Tirzepatide Comparison

The short answer

As of September 5, 2026, Zepbound comes four ways and the needle answer depends on which you have. The single-dose pen has a hidden, built-in needle whose gauge and length Lilly does not publish; you never see or choose it. The Zepbound KwikPen (launched February 23, 2026) takes standard pen needles that are not included; Lilly lists compatible pen needles from 4 mm to 12.7 mm long and 29 to 34 gauge. Zepbound single-dose vials and compounded tirzepatide vials are drawn with a syringe and needle sold separately; Lilly's example is a 1 mL syringe, and the FITTER injection-technique recommendations favor the shortest needles (4 mm pen needles and 6 mm syringe needles) for all adults.

Table of contents

1. The 30-second answer
2. The Zepbound auto-injector vs compounded tirzepatide vials
3. Built-in needle in the branded Zepbound pen
4. Insulin syringe choices for compounded vials
5. Needle length: how to choose by body composition
6. Needle gauge: comfort vs flow
7. The pinch-up technique and why length matters less than you think
8. What sizes to avoid
9. Where to buy syringes for compounded tirzepatide
10. Replacing needles between draws
11. Zepbound KwikPen: which pen needles fit
12. Zepbound single-dose vial: syringe and needle
13. Corrections, September 2026
14. FAQ
15. Footer disclaimers

The Zepbound auto-injector vs compounded tirzepatide vials

There are now several delivery formats for tirzepatide, and the needle question depends on which you have. Branded Zepbound alone ships as a single-dose pen, a single-dose vial, a multi-dose vial and a four-dose KwikPen (Zepbound prescribing information, revised 08/2026). Compounded tirzepatide usually comes in a vial.

Branded Zepbound (Eli Lilly): A pre-filled, single-use auto-injector. The needle is housed inside the device, has a fixed length and gauge, and the user does not choose or change it. One pen, one weekly dose, one disposal. The user never touches the needle.

Zepbound KwikPen (Eli Lilly): A single-patient-use pen holding four weekly doses of one strength, launched in the US on February 23, 2026. Pen needles are not included; you attach a new KwikPen-compatible pen needle for each injection, and the pen is discarded after four doses.

Zepbound single-dose vial (Eli Lilly): One weekly dose in 0.5 mL. The instructions for use say the syringe and needle are supplied separately, give a 1 mL syringe and needle as recommended by your healthcare provider as the example, and say to use a new syringe and needle for every injection and discard any leftover medicine.

Compounded tirzepatide: Prepared by a state-licensed compounding pharmacy, usually in a multi-dose vial. The patient draws each weekly dose with a syringe, then injects subcutaneously. Here, the user selects the syringe and needle size from what the pharmacy ships or what they buy separately.

These are different products from a delivery standpoint. The branded auto-injector is engineered around a specific needle. The compounded vial allows flexibility, which is helpful but adds a decision point.

Built-in needle in the branded Zepbound pen

Correction, September 2026: an earlier version of this page stated that the Zepbound pen contains a 5 mm, 30-gauge needle and attributed that to the Lilly patient leaflet. Lilly does not publish the gauge or length of the pen's needle in the prescribing information or the instructions for use; the figure could not be traced to any published source and has been removed. What the instructions for use (2026) do say:

• Length and gauge: not published. Lilly's documents do not state them, and any number you see online for the single-dose pen is unsourced.
• Do not touch the needle. The pen has a gray base cap that covers the needle until you inject.
• Position: hidden inside the housing, advanced and retracted automatically by the device mechanism.
• Single use: the needle is part of the disposable pen and is not removable, replaceable, or reusable.

For context, modern pen needles are short by historical standards. The FITTER international injection-technique recommendations (Frid et al., Mayo Clinic Proceedings, 2016) concluded that the shortest needles, 4 mm pen needles and 6 mm syringe needles, are safe, effective and less painful and should be first-line for all patient categories, because subcutaneous fat at the standard sites (abdomen, thigh, upper arm) is reliably reachable with them when technique is right.

For most users at most body compositions, the pen's built-in needle works at the abdomen, thigh or upper arm, which are the three sites the label allows. Lean patients injecting at the thigh or upper arm sometimes feel the needle reach muscle, in which case a pinch-up technique helps. (See our tirzepatide injection technique guide for the pinch-up walkthrough.)

Insulin syringe choices for compounded vials

For tirzepatide drawn from a vial, whether a Zepbound single-dose vial or a compounded multi-dose vial, the usual tool is a 1 mL U-100 insulin syringe (the Zepbound vial instructions give a 1 mL syringe as the example). "U-100" refers to the syringe's calibration: 100 units per mL. The syringe has both a barrel and an attached fixed needle (most insulin syringes are integrated, no separate needle).

Common configurations. The lengths and gauges below are the ones embecta (formerly BD) lists for its Ultra-Fine insulin syringes: 6 mm (15/64 inch), 8 mm (5/16 inch) and 12.7 mm (1/2 inch) needles in 29 to 31 gauge, in 0.3, 0.5 and 1 mL barrels. The best-for column is general guidance, not a manufacturer recommendation.

Syringe type	Length	Gauge	Best for
1 mL U-100, 15/64 inch	6 mm	31G	Shortest syringe needle; FITTER 2016 recommends 6 mm syringe needles first-line for adults
1 mL U-100, 5/16 inch	8 mm	31G	Standard adult, average body composition
1 mL U-100, 1/2 inch	12.7 mm	29G	Higher BMI or sites with deep SC fat
1 mL U-100, 5/16 inch	8 mm	30G	Standard, slightly thicker needle for higher viscosity
0.3 mL or 0.5 mL U-100, 5/16 inch	8 mm	31G	Smaller dose volumes

The pharmacy typically ships syringes that match the dose volume and concentration of the compounded vial they prepared. If your pharmacy ships syringes, use what they sent. If you're ordering separately, the 1 mL, 5/16 inch, 31G is the most common combination.

Key terminology:

• Length refers to the needle, not the syringe barrel. A 5/16 inch needle is 8 mm.
• Gauge measures needle thickness, with higher numbers being thinner. 31G is thinner than 29G.
• U-100 means the markings count units of insulin (or for compounded GLP-1, units of medication where the conversion depends on the concentration).

Needle length: how to choose by body composition

The right needle length is the one that places the medication in subcutaneous fat without reaching muscle.

5/16 inch (8 mm). Works for most adults at the abdomen, including patients with BMI 35 and above. Works at the thigh for most patients with average to higher body fat. May reach muscle at the upper arm in lean patients without a pinch.

1/2 inch (12.7 mm). Used by patients who feel the 8 mm needle is too short to reliably reach SC fat at deeper-fat sites. More common in patients with significant abdominal adiposity. Less common at thighs and upper arms.

4 mm to 12.7 mm pen needles (Zepbound KwikPen). Pen needles screw onto the KwikPen and are not included with it. Lilly lists compatible ISO 11608-2 pen needles from embecta (formerly BD), Novo Nordisk and Terumo in 4, 5, 6, 8 and 12.7 mm lengths and 29 to 34 gauge, noting that not every combination is sold (Lilly medicine FAQ, 02/2026). Lilly's UK medical team says 4 mm pen needles are suitable for adults using the tirzepatide KwikPen (reviewed August 14, 2025), which matches the FITTER recommendation. For vials, 6 mm or 8 mm syringe needles are the typical starting choices.

A few practical points:

• The same patient may need different lengths at different sites. The abdomen has the most SC fat in most adults. The arm has the least.
• Significant weight loss can change which length is right. A patient who started with 12.7 mm at BMI 38 may switch to 8 mm at BMI 28.
• The pinch-up technique compensates for short needles in lean patients. Pinching a fold of skin and fat away from the muscle gives even a 5 mm needle a clear SC target.

Needle gauge: comfort vs flow

Gauge is a tradeoff between injection comfort and how easily the medication flows through the needle.

Thinner needles (higher gauge, like 31G or 32G):

• Less painful insertion.
• Easier to inject with one hand for self-injectors.
• Slower flow rate, which means a slightly slower injection.
• Higher risk of needle bending, especially if reused or hitting tissue at an angle.

Thicker needles (lower gauge, like 29G or 28G):

• More noticeable insertion.
• Faster flow rate, useful for thicker compounded preparations.
• More resistant to bending.
• Easier to draw thick fluid from a vial.

For compounded tirzepatide at the concentrations pharmacies commonly dispense, a 31G needle handles flow well and minimizes injection discomfort. Patients who find the injection painful can often switch to 32G for less sensation. Patients drawing from thicker preparations sometimes prefer 30G or 29G for faster vial draw, then accept slightly more injection sensation.

Lilly does not publish the gauge of the single-dose pen's needle, so it cannot be placed on this scale. For the KwikPen, the compatible range is 29 to 34 gauge.

The pinch-up technique and why length matters less than you think

Patients overweight the importance of needle length and underweight the importance of technique. A 4 mm or 6 mm needle inserted with proper technique is more reliably subcutaneous than a 12.7 mm needle inserted at a poor angle, which is the core finding behind the FITTER 2016 recommendations.

The pinch-up technique:

1. Pinch a 1-2 inch fold of skin and fat between your thumb and index finger.
2. Lift the fold away from the underlying muscle. The fold creates a target that is entirely subcutaneous.
3. Insert the needle perpendicular to the surface of the pinch.
4. Inject slowly. Hold for the recommended time (5 to 10 seconds).
5. Withdraw the needle, then release the pinch.

For lean patients, the pinch-up is essential at the thigh and upper arm regardless of needle length. For higher-BMI patients, the pinch-up is optional at the abdomen but helps with reproducibility.

The 90-degree question:

Most pen-needle and short insulin-syringe injections are done at 90 degrees to the skin. This works because the needle is short enough to reach SC fat directly without going deeper. For the older 12.7 mm needles, some practitioners taught a 45-degree angle to avoid IM placement. With modern 4 to 8 mm needles, 90 degrees is standard, with a pinch where the site is lean.

What sizes to avoid

A few configurations that aren't appropriate for tirzepatide subcutaneous injection:

Needles longer than 1/2 inch (12.7 mm). Too long for SC injection at any site for most adults. Risk of muscle injection.

Insulin pen needles applied to a non-pen syringe. Pen needles are designed to screw onto a pen barrel. They don't fit standard syringes.

Needles shorter than 4 mm (1/8 inch). Some specialty needles exist at this length but are typically for pediatric insulin use. Not standard for adult GLP-1 injection.

Reused needles. Even disposable needles dull and bend after a single use. Reusing a needle increases injection pain, raises infection risk, and produces less reliable dosing. Always use a fresh needle every dose.

Damaged or expired syringes. Check the packaging seal and expiration date. Discard any syringe with bent, dulled, or visibly damaged needles.

Generic, unbranded syringes from non-medical sources. Use FDA-cleared insulin syringes from a pharmacy or licensed medical supply retailer. Cheap imports sometimes have inconsistent gauge, dull tips, or sterility issues.

Where to buy syringes for compounded tirzepatide

Most compounded tirzepatide pharmacies include the syringes with the vial shipment. If you need to buy more or replace a damaged batch:

Source	Pros	Cons
Your compounding pharmacy	Matched to your prescription, reliable	May charge for additional supplies
Local pharmacy (CVS, Walgreens)	Easy access, trusted brands	Rules on selling syringes without a prescription vary by state and by pharmacy
Online medical supply (Walmart Pharmacy online, Allegro Medical, ADW Diabetes)	Bulk pricing, free shipping at volume	Shipping time
Amazon	Convenience, fast delivery	Verify seller is a medical supply company, not a generic reseller

Common brands: BD Ultra-Fine (now made by embecta), Easy Touch, Comfort EZ, Exel Comfort Point. An earlier version of this page quoted a price per box; prices change and were not sourced, so check a current retailer listing.

State prescription requirements:

Requirements for buying syringes without a prescription vary by state and by pharmacy policy, and an earlier version of this page listed ten specific states without a legal source; that list has been removed. Ask your pharmacist, or ask your prescriber to include syringes on the prescription so there is no question.

Replacing needles between draws

For compounded tirzepatide from a multi-dose vial, the question sometimes comes up: should you change syringes between drawing from the vial and injecting?

Standard practice: use a single syringe for both drawing and injecting. The Zepbound vial instructions for use describe drawing the dose and injecting with the same syringe and needle, and say to use a new syringe and needle for every injection. Compounded products have no label, so follow the same approach.

Two-needle technique: some patients use one syringe to draw from the vial, then swap to a fresh syringe for injection. This is less common, requires two syringes per dose, and is mostly used when the vial has a thick rubber stopper that dulls the needle on the draw.

For most compounded tirzepatide vials, the single-syringe approach is fine. The vial stopper is designed for repeated single-syringe access. The needle stays sharp enough across one draw and one injection.

Zepbound KwikPen: which pen needles fit (as of September 5, 2026)

Lilly launched the four-dose Zepbound KwikPen in the US on February 23, 2026, in all six strengths, sold through LillyDirect at launch. Its instructions for use (revised January 2026) say a KwikPen-compatible pen needle is required and not included, that a new needle goes on for every injection, and that the pen is discarded after four doses; the pen will not let you dial a full dose once the four weekly doses are gone.

Lilly's medicine FAQ on needle choice (02/2026) lists compatible ISO 11608-2 pen needles from embecta (formerly BD), Novo Nordisk and Terumo in 4 mm, 5 mm, 6 mm, 8 mm and 12.7 mm lengths and 29 to 34 gauge, with a note that not all length and gauge combinations are available. Lilly's UK medical information team adds that 4 mm pen needles are suitable for adults using the tirzepatide KwikPen (last reviewed August 14, 2025). The prescribing information warns never to share a KwikPen with another person, even if the pen needle is changed.

Presentation	Needle	Included?	Source
Zepbound single-dose pen	Built in, hidden; gauge and length not published	Yes (integrated)	Pen instructions for use, 2026
Zepbound KwikPen (4 doses)	Pen needles 4 to 12.7 mm, 29 to 34G, ISO 11608-2	No	KwikPen instructions for use, January 2026; Lilly FAQ, 02/2026
Zepbound single-dose vial	Syringe and needle, example 1 mL syringe	No	Vial instructions for use, April 2026
Compounded tirzepatide vial	Insulin syringe, commonly 6 or 8 mm, 29 to 31G	Often shipped by the pharmacy	embecta configurations; FITTER 2016

Zepbound single-dose vial: syringe and needle (instructions for use, April 2026)

The Zepbound vial instructions for use (revised April 2026) list what you need as one syringe and one needle, supplied separately, and give the example of a 1 mL syringe and needle as recommended by your healthcare provider. The steps: draw 0.5 mL of air into the syringe, inject the air into the vial, turn it over and withdraw the full 0.5 mL dose, then inject into the abdomen, thigh or upper arm. Each vial is single-dose; discard any leftover medicine and the used syringe and needle after one use, and never reuse either. The vial is sold through LillyDirect self-pay at $299 (2.5 mg), $399 (5 mg) and $449 (7.5 mg and above) when refilled within 45 days of the prior fill, otherwise $499 for 7.5 mg and $699 for 10 to 15 mg; the KwikPen carries the same prices.

Corrections, September 2026

Correction, September 2026: an earlier version of this page stated that the Zepbound pen has a 5 mm, 30-gauge needle, quoted a syringe price per box and per unit, listed ten states as requiring a prescription for syringes, and cited the American Diabetes Association Standards of Care for needle selection. None of these could be traced to a published source and all have been removed or replaced. Needle-length statements now cite the FITTER 2016 recommendations (Frid et al., Mayo Clinic Proceedings), and device statements cite Lilly's instructions for use and pen-needle FAQ. The page did not previously mention the Zepbound KwikPen (launched February 23, 2026) or the Zepbound single-dose vial; both have been added.

FAQ

What needle size does the Zepbound pen come with?

The single-dose Zepbound pen has a built-in needle that Lilly does not describe by gauge or length in any published document; it is hidden under the gray base cap and is not user-changeable. The Zepbound KwikPen is different: it does not come with needles, and takes compatible pen needles from 4 to 12.7 mm and 29 to 34 gauge.

Can I change the needle on a Zepbound pen?

Not on the single-dose pen: its needle is integrated and the whole pen is disposed of after one use. On the Zepbound KwikPen you must attach a new pen needle for every injection and remove it afterward; the pen is discarded after its four doses.

What needle should I use for compounded tirzepatide?

A 1 mL U-100 insulin syringe with a 6 mm (15/64 inch) or 8 mm (5/16 inch), 30G or 31G needle is the usual choice; FITTER 2016 recommends the 6 mm syringe needle first-line. Some patients with deeper abdominal fat use 12.7 mm (1/2 inch), 29G. Your compounding pharmacy typically ships syringes that match your prescription.

Is a 5/16 inch needle long enough for someone at higher body weight?

For abdomen injections at most BMIs, yes. Subcutaneous fat at the abdomen is generally deep enough that a 5/16 inch (8 mm) needle reaches it reliably. Patients with very deep abdominal fat sometimes prefer 1/2 inch (12.7 mm). Body composition matters more than total weight.

Is 31G painful for tirzepatide injection?

31G is one of the thinnest standard gauges. Most patients describe it as a small sting rather than sharp pain. The injection itself is much less uncomfortable than an IM vaccine or blood draw. Patients who find it uncomfortable can try 32G, which is slightly thinner.

Can I use a regular hypodermic needle for tirzepatide?

You can technically use any subcutaneous needle, but the standard is a U-100 insulin syringe because the dose calibration matches how compounded tirzepatide is measured (in units). A regular hypodermic syringe with cc/mL markings requires you to convert from the pharmacy's unit-based instructions, which adds a step where errors happen.

What's the difference between a 4 mm and a 5 mm needle?

Both are short pen needles intended for subcutaneous injection, and both are on Lilly's compatibility list for the Zepbound KwikPen. FITTER 2016 found 4 mm pen needles safe and effective for all adults, and Lilly's UK medical team says 4 mm is suitable for adults using the tirzepatide KwikPen. The 1 mm difference matters most at lean injection sites.

Should I use a longer needle if my injections sometimes leak medication back out?

A small amount of "back-leak" is common and usually not a sign that the needle is too short. The fix is usually slower injection (5 to 10 seconds), holding the needle in place for several seconds after injection, and pinching the skin to keep the SC depot intact. Switching to a longer needle without addressing technique often doesn't solve leakage.

Can I reuse insulin syringes for multiple injections?

No. Single-use only. Reused needles dull, bend, increase injection pain, and raise infection risk. The Zepbound vial instructions say to use a new syringe and needle for every injection, and the KwikPen instructions say to attach a new pen needle each time.

What gauge is best for drawing tirzepatide from a thick vial?

For typical compounded tirzepatide preparations, 30G or 31G handles flow well. If you have a particularly viscous preparation, 29G (slightly thicker) draws faster but sacrifices some injection comfort. Most patients don't need to change gauge based on draw speed.

Do I need a prescription for insulin syringes?

It varies by state and by pharmacy policy, so ask your pharmacist. The simplest route is to have your prescriber include syringes (or pen needles for the KwikPen) on the prescription. Your compounding pharmacy can ship syringes alongside the vial, and Lilly's Zepbound vial and KwikPen do not include needles.

What's the longest needle I should use for tirzepatide?

1/2 inch (12.7 mm) is the standard upper limit for SC injection. Anything longer risks IM placement, which changes the absorption kinetics and isn't what the dosing schedule assumes. (See our Zepbound storage guide for related handling instructions and the Zepbound pen disposal guide for what to do after injection.)

Does the Zepbound KwikPen come with needles?

No. The KwikPen instructions for use (revised January 2026) say a KwikPen-compatible pen needle is required and not included, and Lilly's needle FAQ (02/2026) lists compatible pen needles from embecta (formerly BD), Novo Nordisk and Terumo in 4 to 12.7 mm lengths and 29 to 34 gauge. Ask your prescriber to add pen needles to the prescription, or buy them at a pharmacy. Use a new needle for each of the four doses.

How big is the needle in the Zepbound pen?

Lilly does not say. Neither the Zepbound prescribing information (revised 08/2026) nor the single-dose pen instructions for use give the needle's gauge or length; the instructions only say the needle is covered by the gray base cap and not to touch it. Numbers circulating online for the pen, including one this page used to carry, are unsourced. You never handle the needle, and the pen injects automatically when pressed against the skin.

What syringe do I use with a Zepbound vial?

The vial instructions for use (revised April 2026) say the syringe and needle are supplied separately and give a 1 mL syringe and needle as recommended by your healthcare provider as the example. You draw the full 0.5 mL dose, inject, and discard the vial, syringe and needle after that single use. A U-100 insulin syringe with a 6 mm or 8 mm, 29 to 31 gauge needle is a typical choice; FITTER 2016 recommends 6 mm syringe needles first-line.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Zepbound prescribing information (revised 08/2026) and the Lilly instructions for use for the single-dose pen, single-dose vial and KwikPen, Lilly's pen-needle compatibility FAQ, the embecta (BD) Ultra-Fine syringe configurations, and the FITTER injection-technique recommendations (Frid et al., Mayo Clinic Proceedings, 2016). An earlier version cited the American Diabetes Association Standards of Care for needle selection; that document does not specify syringe gauge or length and the citation has been replaced. Updated September 5, 2026.

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic is a registered trademark of Novo Nordisk A/S. BD UltraFine, Easy Touch, Comfort EZ, and Exel are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by these companies.

Sources

1. Eli Lilly and Company. Zepbound (tirzepatide) injection, US prescribing information, revised 08/2026. https://pi.lilly.com/us/zepbound-uspi.pdf
2. Eli Lilly and Company. Instructions for use, Zepbound single-dose pen, 2026. https://pi.lilly.com/us/zepbound-pen-us-ifu.pdf
3. Eli Lilly and Company. Instructions for use, Zepbound single-dose vial, revised April 2026. https://pi.lilly.com/us/zepbound-vial-us-ifu.pdf
4. Eli Lilly and Company. Instructions for use, Zepbound KwikPen, revised January 2026. https://pi.lilly.com/us/zepbound-kwikpen-us-ifu.pdf
5. Eli Lilly and Company. Medicine FAQ: which pen needles are recommended for the Zepbound KwikPen, 02/2026. https://www.lilly.com/en-ca/medicines/medicine-faqs/zepbound-kwikpen/needle-recommendation
6. Eli Lilly and Company (UK). What needles are recommended for the Mounjaro (tirzepatide) KwikPen, last reviewed August 14, 2025. https://medical.lilly.com/uk/products/answers/what-needles-are-recommended-for-the-mounjaro-tirzepatide-kwikpen-217610
7. Eli Lilly and Company. Press release: Zepbound now available in multi-dose KwikPen, February 23, 2026. https://www.prnewswire.com/news-releases/zepbound-tirzepatide-the-most-prescribed-weight-management-medication-in-2025-now-available-in-multi-dose-kwikpen-302693937.html
8. Eli Lilly and Company. LillyDirect Zepbound self-pay pricing, 2026. https://www.lilly.com/lillydirect/zepbound
9. Frid AH et al. New insulin delivery recommendations (FITTER). Mayo Clinic Proceedings, 2016. https://europepmc.org/article/MED/27594187